<DOC>
	<DOC>NCT01115946</DOC>
	<brief_summary>This study is to assess the effect of ASP1585 on pharmacokinetics of enalapril in 2x2 crossover method.</brief_summary>
	<brief_title>A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Enalapril in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Enalaprilat</mesh_term>
	<criteria>Body weight: =&lt;50.0kg, &lt;80.0kg Body mass index: =&lt;17.6, &lt;26.4 Healthy as judged by investigator or caregiver from subjective and objective symptoms and physical examination data Attending another clinical trial within 120 days before the study Blood donation within 90 days (400ml) or 30 days (200ml) before the study Receiving any drugs within 7 days before the study History of allergy to drugs Having GI disorders History or complication of liver diseases History or complication of heart disease History or complication of respiratory diseases History or complication of renal diseases History or complication of cerebrovascular diseases</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>ASP1585</keyword>
	<keyword>Drug-drug interaction</keyword>
	<keyword>enalapril</keyword>
	<keyword>Healthy volunteer</keyword>
</DOC>